Identification of putative germline mutations in 10,288 patients undergoing circulating tumor DNA testing.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Thomas Paul Slavin, Kimberly Banks, Darya Chudova, Geoffrey R. Oxnard, Justin I. Odegaard, Rebecca J Nagy, Susan L. Neuhausen, Stacy W. Gray, Massimo Cristofanilli, Angel Augusto Rodriguez, Aditya Bardia, Brian Leyland-Jones, Mike Janicek, Michael B. Lilly, Guru Sonpavde, Christine E. Lee, Richard B. Lanman, Funda Meric-Bernstam, Razelle Kurzrock, Jeffrey N. Weitzel
Institutions: City Of Hope National Medical Center, Guardant (United States), Dana-Farber Cancer Institute, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Houston Methodist, Massachusetts General Hospital, Avera Health, Arizona Oncology, Medical University of South Carolina, University of Alabama at Birmingham, The University of Texas MD Anderson Cancer Center, University of California San Diego, Moores Cancer Center
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2679604777